Informa Life Sciences is part of the Knowledge and Networking Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.
Dr. Jonas Helma-Smets, PhD, is a group leader at Tubulis Technologies, a spin-off project at Ludwig-Maximilians University Munich (LMU), focusing on conjugation technologies for next-generation Antibody Drug Conjugates (ADCs). Before founding Tubulis, he conducted post-doctoral research at LMU (2013-2017) on site-specific protein functionalization and single domain antibodies as novel research reagents for cell biological applications. Previously, he co-founded ChromoTek GmbH (2008-2014), a Biotech spin-off, developing highly specific reagents for protein purification and superresolution microscopy. His research work has focused on innovations in technology development and recombinant antibodies for diagnostic and therapeutic purposes.